Movement Alert｜QingSong Health Rises 10.14% in Regular Trading, AI Medical Agent MedClaw Selected as Typical Case at Global Digital Economy Conference

Market Focus07-07

On July 7, QingSong Health rose 10.14% in regular trading, trading at HKD 10.42/share, with turnover of HKD 134 million.

On the news front, QingSong Health's proprietary evidence-based medicine AI agent \"MedClaw\" was selected as a typical case in the AI-Empowered Scenario Applications collection at the Global Digital Economy Conference, marking the company's medical AI transition from model demonstration to real-world scenario validation. MedClaw has launched over 2,000 standardized Skills covering nine core medical scenarios and has passed all 13 functional use case evaluations by the China Academy of Information and Communications Technology.

Additionally, the company is executing an up to HKD 100 million share buyback program. On July 2, QingSong Health repurchased 2.972 million shares in a single day at prices between HKD 9.69 and HKD 10.74, paying approximately HKD 29.89 million. As of the latest disclosure, the company has repurchased a cumulative 5.012 million shares under the authorization, with approximately 15.63 million shares remaining available for repurchase, continuing to signal confidence to the market.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1143644072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 14:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143644072","market":"us","top_or_hot":-1,"title":"Movement Alert｜QingSong Health Rises 10.14% in Regular Trading, AI Medical Agent MedClaw Selected as Typical Case at Global Digital Economy Conference","media":"Market Focus","content":"<p><p>On July 7, QingSong Health rose 10.14% in regular trading, trading at HKD 10.42/share, with turnover of HKD 134 million.</p><p>On the news front, QingSong Health's proprietary evidence-based medicine AI agent \\\"MedClaw\\\" was selected as a typical case in the AI-Empowered Scenario Applications collection at the Global Digital Economy Conference, marking the company's medical AI transition from model demonstration to real-world scenario validation. MedClaw has launched over 2,000 standardized Skills covering nine core medical scenarios and has passed all 13 functional use case evaluations by the China Academy of Information and Communications Technology.</p><p>Additionally, the company is executing an up to HKD 100 million share buyback program. On July 2, QingSong Health repurchased 2.972 million shares in a single day at prices between HKD 9.69 and HKD 10.74, paying approximately HKD 29.89 million. As of the latest disclosure, the company has repurchased a cumulative 5.012 million shares under the authorization, with approximately 15.63 million shares remaining available for repurchase, continuing to signal confidence to the market.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜QingSong Health Rises 10.14% in Regular Trading, AI Medical Agent MedClaw Selected as Typical Case at Global Digital Economy Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜QingSong Health Rises 10.14% in Regular Trading, AI Medical Agent MedClaw Selected as Typical Case at Global Digital Economy Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-07 14:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 7, QingSong Health rose 10.14% in regular trading, trading at HKD 10.42/share, with turnover of HKD 134 million.</p><p>On the news front, QingSong Health's proprietary evidence-based medicine AI agent \\\"MedClaw\\\" was selected as a typical case in the AI-Empowered Scenario Applications collection at the Global Digital Economy Conference, marking the company's medical AI transition from model demonstration to real-world scenario validation. MedClaw has launched over 2,000 standardized Skills covering nine core medical scenarios and has passed all 13 functional use case evaluations by the China Academy of Information and Communications Technology.</p><p>Additionally, the company is executing an up to HKD 100 million share buyback program. On July 2, QingSong Health repurchased 2.972 million shares in a single day at prices between HKD 9.69 and HKD 10.74, paying approximately HKD 29.89 million. As of the latest disclosure, the company has repurchased a cumulative 5.012 million shares under the authorization, with approximately 15.63 million shares remaining available for repurchase, continuing to signal confidence to the market.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02661","symbol_name":"轻松健康","start_time":0,"source_url":"","article_id":"1143644072","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143644072","pubTimestamp":1783406540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 7, QingSong Health rose 10.14% in regular trading, trading at HKD 10.42/share, with turnover of HKD 134 million.On the news front, QingSong Health's proprietary evidence-based medicine AI...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02661":"轻松健康"},"translate_title":"动感快讯|青松健康常规交易涨10.14%AI医疗代理MedClaw入选全球数字经济大会典型案例","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02661":1},"content_text":"On July 7, QingSong Health rose 10.14% in regular trading, trading at HKD 10.42/share, with turnover of HKD 134 million.On the news front, QingSong Health's proprietary evidence-based medicine AI agent \\\"MedClaw\\\" was selected as a typical case in the AI-Empowered Scenario Applications collection at the Global Digital Economy Conference, marking the company's medical AI transition from model demonstration to real-world scenario validation. MedClaw has launched over 2,000 standardized Skills covering nine core medical scenarios and has passed all 13 functional use case evaluations by the China Academy of Information and Communications Technology.Additionally, the company is executing an up to HKD 100 million share buyback program. On July 2, QingSong Health repurchased 2.972 million shares in a single day at prices between HKD 9.69 and HKD 10.74, paying approximately HKD 29.89 million. As of the latest disclosure, the company has repurchased a cumulative 5.012 million shares under the authorization, with approximately 15.63 million shares remaining available for repurchase, continuing to signal confidence to the market.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1143644072","isCrawlerRequest":true}